Contact
Please use this form to send email to PR contact of this press release:
EAGLE PHARMACEUTICALS INVESTOR ALERT: Hagens Berman Alerts Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) Investors to Securities Class Action and August 1, 2016 Lead Plaintiff Deadline
TO: